Pregled bibliografske jedinice broj: 228617
Phase I and Phase II Docetaxel-Estramustine therapy in Stage D3 prostate cancer patients, A case report.
Phase I and Phase II Docetaxel-Estramustine therapy in Stage D3 prostate cancer patients, A case report. // Book of Abstracts, The 12th International Prostate Cancer Update / David E Crawford (ur.).
Denver (CO): ICPME, 2002. str. 363-363 (predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 228617 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Phase I and Phase II Docetaxel-Estramustine therapy in Stage D3 prostate cancer patients, A case report.
Autori
Tarle, Marko ; Kraljić, Ivo ; Kovačić, Ksenija
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Book of Abstracts, The 12th International Prostate Cancer Update
/ David E Crawford - Denver (CO) : ICPME, 2002, 363-363
Skup
The 12th International Prostate Cancer Update
Mjesto i datum
Keystone (CO), Sjedinjene Američke Države, 06.02.2002. - 10.02.2002
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
prostate cancer; Stage D3; chemotherapy; advantage phase II over phase I protocol; improvement in bone lesions
Sažetak
In a case of Stage D3 prosatte cancer we have shown the superiority of phase II protocol over phase I with a substantail improvement in PSA and PAP level and even more in none metastases.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
